Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

55%

6 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 4

4(36.4%)

Phase 3

2(18.2%)

N/A

2(18.2%)

Phase 1

2(18.2%)

Phase 2

1(9.1%)

11Total

Phase 4(4)

Phase 3(2)

N/A(2)

Phase 1(2)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05020574Phase 2Recruiting

Microbiome and Association With Implant Infections

Role: collaborator

NCT05316324Phase 3Active Not Recruiting

A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction

Role: collaborator

NCT04204668Not ApplicableWithdrawn

Surgical Treatments for Neuroma Pain in Amputees

Role: collaborator

NCT06695195Phase 1Not Yet Recruiting

A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain

Role: collaborator

NCT04631185Not ApplicableCompleted

Surgical Site Infection and Antibiotic Use Study

Role: lead

NCT04947514Phase 4Completed

Use of Tranexamic Acid in Reduction Mammoplasty

Role: collaborator

NCT02161705Phase 3Terminated

Pre-op Paravertebral Blocks to Decrease Post-op Pain Following Mastectomy With Immediate Tissue Expander (TE) Reconstruction

Role: collaborator

NCT03213249Phase 1Completed

Bacterial Biofilms in Reconstructive Breast Prostheses Following Mastectomy

Role: collaborator

NCT01398982Phase 4Completed

TAP Block in DIEP or Free MS-TRAM Donor Site: A RCT

Role: collaborator

NCT01244698Phase 4Completed

Postoperative Antibiotic Requirements Following Immediate Breast Reconstruction

Role: collaborator

NCT01113606Phase 4Completed

A Trial of Skin Care Protocols for Facial Resurfacing

Role: lead

All 11 trials loaded